Clal Insurance’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6
Closed -$2K 220
2025
Q3
$2K Sell
6
-21
-78% -$6.53K ﹤0.01% 212
2025
Q2
$11K Sell
27
-2
-7% -$804 ﹤0.01% 183
2025
Q1
$13K Buy
29
+23
+383% +$9.23K ﹤0.01% 176
2024
Q4
$2K Buy
+6
New +$2.51K ﹤0.01% 172
2019
Q4
Sell
-55,000
Closed -$13.2M 119
2019
Q3
$13.2M Buy
+55,000
New +$15.1M 0.32% 64

Other funds holding ELV

Clal Insurance's ELV Position: Q4 2025 in Review

Clal Insurance sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 6 shares — an estimated $2K sold.

Clal Insurance first reported a position in ELV in Q3 2019 and held it in 5 quarters. The position peaked at $13.2M in Q3 2019. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Clal Insurance reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Clal Insurance sold 6 Elevance Health shares in Q4 2025, an estimated $2K.
  • Clal Insurance first reported a position in Elevance Health in Q3 2019 and held it in 5 quarters.
  • Clal Insurance's Elevance Health position peaked at $13.2M in Q3 2019.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Clal Insurance's 13F filing for Q4 2025, filed 13 Feb 2026.